In Vitro Activities of Quinupristin-Dalfopristin and the Streptogramin RPR 106972 against Mycoplasma pneumoniae-Reference-Cited by-同舟云学术

In Vitro Activities of Quinupristin-Dalfopristin and the Streptogramin RPR 106972 against Mycoplasma pneumoniae

Published:1998-03 Issue:3 Volume:42 Page:698-699
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Izumikawa Koichi¹,Hirakata Yoichi¹,Yamaguchi Toshiyuki¹,Yoshida Ryoji²,Tanaka Hironori²,Takemura Hiromu³,Maesaki Shigefumi²,Tomono Kazunori²,Kaku Mitsuo³,Izumikawa Kin-Ichi⁴,Kamihira Shimeru¹,Kohno Shigeru²

Affiliation:

1. Department of Laboratory Medicine1 and

2. Second Department of Internal Medicine,2 Nagasaki University School of Medicine, Nagasaki 852,

3. Department of Microbiology, St. Marianna University School of Medicine, Kawasaki 211,3 and

4. Izumikawa Hospital, Nagasaki 859-15,4 Japan

Abstract

ABSTRACT The in vitro activities of quinupristin-dalfopristin and streptogramin RPR 106972 were determined with 44 strains of Mycoplasma pneumoniae and compared to those of macrolides, minocycline, and quinolones. All isolates tested were highly susceptible to macrolides and to quinupristin-dalfopristin (MIC at which 90% of the isolates are inhibited [MIC 90 ], 0.0625 μg/ml), followed by RPR 106972 (MIC 90 , 0.5 μg/ml), quinolones, and minocycline.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.42.3.698

Reference14 articles.

1. The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens.;Andrews J. M.;J. Antimicrob. Chemother.,1994

2. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens

3. Quinupristin-dalfopristin.;Bryson H. M.;Drugs,1996

4. Growth on artificial medium of an agent associated with atypical pneumonia and its identification as PPLO.;Chanock R. M.;Proc. Natl. Acad. Sci. USA,1962

5. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Susceptibilities of Mycoplasma hominis, M. pneumoniae , and Ureaplasma urealyticum to GAR-936, Dalfopristin, Dirithromycin, Evernimicin, Gatifloxacin, Linezolid, Moxifloxacin, Quinupristin-Dalfopristin, and Telithromycin Compared to Their Susceptibilities to Reference Macrolides, Tetracyclines, and Quinolones;Antimicrobial Agents and Chemotherapy;2001-09

2. Novel streptogramin antibiotics;Expert Opinion on Investigational Drugs;2001-02

3. Sensibilidad in vitro actual de los patógenos respiratorios bacterianos más frecuentes: implicaciones clínicas;Medicina Clínica;2001

4. Quinupristin-Dalfopristin: An Overview;Pharmacotherapy;2000-12

5. Evaluation of quinupristin/dalfopristin (Synercid®) and RPR 106 972 stability in susceptibility testing media;International Journal of Antimicrobial Agents;2000-08